THE 15^th IATDMCT CONGRESS: Expansion and Evolution of TDM/CT
This month we are bringing to you an article from the June 2017 Compass which provides an exciting overview on the upcoming IATDMCT 2017 Congress, Kyoto, Japan.  It highlights important dates, registration information, scientific program details, social events and the planned Young Scientists activities.

We look forward to seeing you all in Kyoto!

Many thanks to Organisers for this article:
Yusuke Tanigawara (Congress Chair, right) 
Takehito Yamamoto (IATDMCT YS Committee member), far right)

The IATDMCT Congress is fast approaching, and the March 2017 Compass opens with a useful overview of practical information for members.  Scientific reports include the current state of Vancomycin TDM, which despite more than five decades of clinical application, continues to pose challenges: novel approaches are being refined for clinical use. We revisit medicinal use of cannabis, this time from the perspective of the Toxicology Committee, and we hear about laboratory assays aimed at determining idiosyncratic, Type B, adverse drug reactions.  Finally, our German colleagues share details about a special event held to celebrate the retirement of Hans Maurer, IATDMCT past-president, who took his bow with a presentation about potions and poisons in opera and the arts: well worth a read.

Many thanks to the Compass Editorial Team:

Paula Schaiquevich
Edgar Spencer
Franck Saint-Marcoux

This month we hear from fellow Australian and colleague, Jason Roberts, whose work is recognized for advancing research in TDM to serve the critical patient, especially optimising the use of antimicrobial drugs. Building on previous work, Jason and his colleagues perform outstanding research from routine clinical work, as well as leading and participating in high quality international collaborations. Jason shares about these and various other initiatives.

Jason Roberts
Consultant Clinical Pharmacist, Royal Brisbane and Women’s Hospital
Professor & NHMRC Practitioner Fellow, Centre for Clinical Research University of Queensland, Australia

We’re a month behind in reporting on the most recent Compass, principally because Prof Christians’ Interview was too compelling to push back. The December issue completed the year’s circuit of meetings, where IATDMCT members were involved in Regional meetings and Scientific Committee initiatives, among other international meetings and congresses. Among the great reports from SCs, members of the Drugs of Abuse Committee bring our attention to medicinal use of Cannabis, and suggest our Association keep an eye on emerging developments.

Many thanks to the Compass Editorial Team:

Paula Schaiquevich
Edgar Spencer
Franck Saint-Marcoux